Underrepresentation occurs when training data includes a population, structure, or condition less often than its relevant real-world distribution. This imbalance can reduce model accuracy and limit generalization in drug discovery and clinical prediction. section 13.4.3
Drug-discovery datasets show underrepresentation in several forms:
- Protein structure data contains 91% soluble proteins but only 3–4% membrane proteins, although membrane proteins comprise about 30% of human proteins. section 13.4.3
- Small-molecule datasets emphasize compounds within Lipinski’s Rule of Five, leaving larger molecules and macrocycles less represented. section 13.4.3
- Clinical prediction data underrepresents some racial and ethnic groups, geographic regions, and age groups, weakening generalization across patients. section 13.4.3

